Cargando…

How Can the National Burden of Parkinson’s Disease Comorbidity and Mortality Be Estimated for the Japanese Population?

BACKGROUND: Good medical care results in long survival for patients with Parkinson’s disease (PD). However, little is known about the burden of PD comorbidity and mortality in Japan. This is the first study to examine comorbid diseases of PD decedents and extrapolate PD death rates from multiple-cau...

Descripción completa

Detalles Bibliográficos
Autores principales: Doi, Yuriko, Yokoyama, Tetsuji, Nakamura, Yoshikazu, Nagai, Masaki, Fujimoto, Kenichi, Nakano, Imaharu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japan Epidemiological Association 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3899411/
https://www.ncbi.nlm.nih.gov/pubmed/21422700
http://dx.doi.org/10.2188/jea.JE20100149
_version_ 1782300571153203200
author Doi, Yuriko
Yokoyama, Tetsuji
Nakamura, Yoshikazu
Nagai, Masaki
Fujimoto, Kenichi
Nakano, Imaharu
author_facet Doi, Yuriko
Yokoyama, Tetsuji
Nakamura, Yoshikazu
Nagai, Masaki
Fujimoto, Kenichi
Nakano, Imaharu
author_sort Doi, Yuriko
collection PubMed
description BACKGROUND: Good medical care results in long survival for patients with Parkinson’s disease (PD). However, little is known about the burden of PD comorbidity and mortality in Japan. This is the first study to examine comorbid diseases of PD decedents and extrapolate PD death rates from multiple-cause coding mortality data for the total population of Japan. METHODS: Data for 4589 certified deaths due to PD as the underlying cause of death (ICD-10 code: G20) were obtained from the 2008 Japanese vital statistics. Of those, comorbidities listed in the death certificates of 477 randomly selected decedents were analyzed. All diseases or conditions mentioned on death certificates were counted and ranked in descending order of frequency. The death rates (per 100 000 population) from PD were calculated using Japanese National Vital Statistics. The estimated rate of deaths with PD was extrapolated using US death data from a multiple-cause coding system, as no such system is available in Japan, with adjustment for the difference in disease structure between countries. RESULTS: Average age at death was 80.9 years. The top 5 comorbid diseases ranked as contributory causes of death were cerebrovascular diseases (4.0%), dementia (3.8%), diabetes mellitus (3.6%), malignant neoplasm (2.5%), and heart diseases (2.3%). Overall, the death rates from and with PD were 3.6 and 5.8, respectively. CONCLUSIONS: Analysis restricted to data from the underlying-cause coding system underestimated the national burden of PD comorbidity and mortality. Use of death certificates and multiple-cause mortality data complement the existing system.
format Online
Article
Text
id pubmed-3899411
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Japan Epidemiological Association
record_format MEDLINE/PubMed
spelling pubmed-38994112014-02-03 How Can the National Burden of Parkinson’s Disease Comorbidity and Mortality Be Estimated for the Japanese Population? Doi, Yuriko Yokoyama, Tetsuji Nakamura, Yoshikazu Nagai, Masaki Fujimoto, Kenichi Nakano, Imaharu J Epidemiol Short Communication BACKGROUND: Good medical care results in long survival for patients with Parkinson’s disease (PD). However, little is known about the burden of PD comorbidity and mortality in Japan. This is the first study to examine comorbid diseases of PD decedents and extrapolate PD death rates from multiple-cause coding mortality data for the total population of Japan. METHODS: Data for 4589 certified deaths due to PD as the underlying cause of death (ICD-10 code: G20) were obtained from the 2008 Japanese vital statistics. Of those, comorbidities listed in the death certificates of 477 randomly selected decedents were analyzed. All diseases or conditions mentioned on death certificates were counted and ranked in descending order of frequency. The death rates (per 100 000 population) from PD were calculated using Japanese National Vital Statistics. The estimated rate of deaths with PD was extrapolated using US death data from a multiple-cause coding system, as no such system is available in Japan, with adjustment for the difference in disease structure between countries. RESULTS: Average age at death was 80.9 years. The top 5 comorbid diseases ranked as contributory causes of death were cerebrovascular diseases (4.0%), dementia (3.8%), diabetes mellitus (3.6%), malignant neoplasm (2.5%), and heart diseases (2.3%). Overall, the death rates from and with PD were 3.6 and 5.8, respectively. CONCLUSIONS: Analysis restricted to data from the underlying-cause coding system underestimated the national burden of PD comorbidity and mortality. Use of death certificates and multiple-cause mortality data complement the existing system. Japan Epidemiological Association 2011-05-05 /pmc/articles/PMC3899411/ /pubmed/21422700 http://dx.doi.org/10.2188/jea.JE20100149 Text en © 2011 Japan Epidemiological Association. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Short Communication
Doi, Yuriko
Yokoyama, Tetsuji
Nakamura, Yoshikazu
Nagai, Masaki
Fujimoto, Kenichi
Nakano, Imaharu
How Can the National Burden of Parkinson’s Disease Comorbidity and Mortality Be Estimated for the Japanese Population?
title How Can the National Burden of Parkinson’s Disease Comorbidity and Mortality Be Estimated for the Japanese Population?
title_full How Can the National Burden of Parkinson’s Disease Comorbidity and Mortality Be Estimated for the Japanese Population?
title_fullStr How Can the National Burden of Parkinson’s Disease Comorbidity and Mortality Be Estimated for the Japanese Population?
title_full_unstemmed How Can the National Burden of Parkinson’s Disease Comorbidity and Mortality Be Estimated for the Japanese Population?
title_short How Can the National Burden of Parkinson’s Disease Comorbidity and Mortality Be Estimated for the Japanese Population?
title_sort how can the national burden of parkinson’s disease comorbidity and mortality be estimated for the japanese population?
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3899411/
https://www.ncbi.nlm.nih.gov/pubmed/21422700
http://dx.doi.org/10.2188/jea.JE20100149
work_keys_str_mv AT doiyuriko howcanthenationalburdenofparkinsonsdiseasecomorbidityandmortalitybeestimatedforthejapanesepopulation
AT yokoyamatetsuji howcanthenationalburdenofparkinsonsdiseasecomorbidityandmortalitybeestimatedforthejapanesepopulation
AT nakamurayoshikazu howcanthenationalburdenofparkinsonsdiseasecomorbidityandmortalitybeestimatedforthejapanesepopulation
AT nagaimasaki howcanthenationalburdenofparkinsonsdiseasecomorbidityandmortalitybeestimatedforthejapanesepopulation
AT fujimotokenichi howcanthenationalburdenofparkinsonsdiseasecomorbidityandmortalitybeestimatedforthejapanesepopulation
AT nakanoimaharu howcanthenationalburdenofparkinsonsdiseasecomorbidityandmortalitybeestimatedforthejapanesepopulation